There is some acknowledgment by employers of their pain problem, but this awareness is not universal. This demonstrates a clear need for solutions that tackle not only health care costs, but absenteeism, the impact to presenteeism, and overall productivity.
AppliedVR released study results demonstrating VR’s ability to help patients suffering from chronic low back pain. The technology was able to increase participants' brain coherence and help them achieve a slower breathing rate — two metrics associated with reduced pain.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Chronic pain, an enduring concern for many older adults, is no longer confined to the traditional realm of pharmaceuticals. While traditional pain management methods like medication were once the go-to approach, alternative therapies are emerging as a viable and holistic approach to addressing this issue.
I look at non-pharmacological approaches like digital therapeutics as having the potential to give someone like me living with chronic pain everything I need to make a healthy recovery: access to digital treatments and clinicians, to community, coaching, and navigation services.
Eli Lilly is paying $40 million up front for rights to a Confo Therapeutics drug in Phase 1 testing as a potential treatment for neuropathic pain. Confo develops drugs that target G-protein coupled receptors.
The future towards the safer treatment of pain will come as biopharma, and investor communities appreciate the significant opportunities in supporting scientifically rigorous and clinically validated lead assets for the safer treatment of pain.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Override provides chronic pain patients with a care team that includes a pain physician, a physical therapist, a psychologist and a coach. The company has received $3.5 million in seed funding and has acquired Take Courage Coaching.
Our nation is severely lacking in its approach to chronic pain. Nobody should ever resign themselves to forever experiencing pain and end their life or the lives of others.
More restrictive opioid prescribing guidelines were put in place in a rightful effort to stop a devastating crisis. But this sudden and dramatic change negatively impacted chronic pain patients who were managing their pain through prescription opioids given few other effective options.
Neuralace Medical, a San Diego-based startup, recently got FDA clearance for a non-invasive device to treat chronic pain. It works by stimulating nerve fibers that have been damaged in a traumatic injury.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Earlier this year, AppliedVR shared results of a pivotal study that it plans to submit to the FDA. It received a breakthrough device designation last year to use its VR platform to treat fibromyalgia and lower back pain.
The Los Angeles-based startup received a breakthrough device designation from the FDA for using VR to manage chronic pain. It recently published the results of a 92-person virtual trial testing VR for pain management at home.
Legislation can help limit the number of pills prescribed, but it will never change the attitudes prevalent in our society that lead people to request opioids in the first-place. Our culture needs a strong dose of reality before we can make any headway in this crisis.
Addressing issues like chronic pain, risk reporting and physician performance, here's a closer look at the companies in the fall 2018 class of Dreamit's HealthTech program.
The issue of chronic pain is one that more and more digital health companies have sought to address, particularly as the healthcare industry seeks alternatives to opioids and surgery.